Related Experiment Videos

Utility of predischarge and one-month transvenous implantable defibrillator tests

J J Goldberger1, G Horvath, S Inbar

  • 1Department of Medicine, Northwestern University, Chicago, Illinois, USA.

Insights

Routine implantable cardioverter-defibrillator (ICD) testing before discharge and at 1 month effectively detects device-related issues. This approach is recommended to ensure patient safety and optimal defibrillation threshold management post-implantation.

Area of Science:

  • Cardiology
  • Biomedical Engineering

Background:

  • Implantable cardioverter-defibrillators (ICDs) are crucial for managing life-threatening arrhythmias.
  • Ensuring optimal device function post-implantation is critical for patient outcomes.

Purpose of the Study:

  • To assess the effectiveness of predischarge and 1-month implantable cardioverter-defibrillator (ICD) testing in identifying device-related complications.
  • To determine the clinical utility of early post-implantation ICD testing protocols.

Main Methods:

  • Evaluation of patients undergoing ICD implantation.
  • Performance of ICD testing prior to hospital discharge.
  • Conducting follow-up ICD testing at the 1-month post-implantation mark.

Main Results:

  • Identified 4 patients with a significant and unacceptable increase in defibrillation threshold.
  • Demonstrated the capability of early testing to detect critical device performance issues.

Conclusions:

  • Predischarge and 1-month follow-up ICD testing are valuable for detecting device-related problems.
  • Routine, non-invasive ICD testing with minimal risk should be standard practice after implantation to ensure safety and efficacy.

Related Concept Videos